The University of Chicago Header Logo

Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival.

Allotransplantation for patients age =40 years with non-Hodgkin lymphoma: encouraging progression-free survival. Biol Blood Marrow Transplant. 2014 Jul; 20(7):960-8.

View in: PubMed